Viewing Study NCT00945269


Ignite Creation Date: 2025-12-24 @ 10:46 PM
Ignite Modification Date: 2025-12-27 @ 8:14 AM
Study NCT ID: NCT00945269
Status: TERMINATED
Last Update Posted: 2022-11-15
First Post: 2009-07-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Therapeutic Autologous Lymphocytes, Aldesleukin, and Denileukin Diftitox in Treating Patients With Stage III-IV Melanoma
Sponsor: Fred Hutchinson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Melanoma View
None Stage III Melanoma View
None Stage IV Melanoma View
Keywords: